Panion BF Valuation
| 1760 Stock | TWD 83.90 1.20 1.41% |
At this time, the company appears to be fairly valued. Panion BF Biotech holds a recent Real Value of NT$84.75 per share. The prevailing price of the company is NT$83.9. Our model determines the value of Panion BF Biotech from analyzing the company fundamentals such as Shares Outstanding of 85.74 M, return on equity of 0.14, and Operating Margin of 0.17 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Panion BF's price fluctuation is very steady at this time. Calculation of the real value of Panion BF Biotech is based on 3 months time horizon. Increasing Panion BF's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Panion stock is determined by what a typical buyer is willing to pay for full or partial control of Panion BF Biotech. Since Panion BF is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Panion Stock. However, Panion BF's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 83.9 | Real 84.75 | Hype 83.9 | Naive 82.54 |
The intrinsic value of Panion BF's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Panion BF's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Panion BF Biotech helps investors to forecast how Panion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Panion BF more accurately as focusing exclusively on Panion BF's fundamentals will not take into account other important factors: Panion BF Total Value Analysis
Panion BF Biotech is presently anticipated to have takeover price of 15.29 B with market capitalization of 14.53 B, debt of 116.07 M, and cash on hands of 350.7 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Panion BF fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.29 B | 14.53 B | 116.07 M | 350.7 M |
Panion BF Investor Information
About 34.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 27th of June 2022. Panion BF Biotech had 1100:1000 split on the 14th of July 2017. Panion BF Biotech is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Panion BF Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Panion BF has an asset utilization ratio of 64.38 percent. This indicates that the Company is making NT$0.64 for each dollar of assets. An increasing asset utilization means that Panion BF Biotech is more efficient with each dollar of assets it utilizes for everyday operations.Panion BF Ownership Allocation
Panion BF owns a total of 85.74 Million outstanding shares. Panion BF has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Panion BF Profitability Analysis
The company reported the revenue of 1.9 B. Net Income was 104.4 M with profit before overhead, payroll, taxes, and interest of 912.14 M.About Panion BF Valuation
Our relative valuation model uses a comparative analysis of Panion BF. We calculate exposure to Panion BF's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Panion BF's related companies.Panion Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. Panion Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei City, Taiwan. PANION BF operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
8 Steps to conduct Panion BF's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Panion BF's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Panion BF's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Panion BF's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Panion BF's revenue streams: Identify Panion BF's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Panion BF's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Panion BF's growth potential: Evaluate Panion BF's management, business model, and growth potential.
- Determine Panion BF's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Panion BF's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Panion Stock Analysis
When running Panion BF's price analysis, check to measure Panion BF's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panion BF is operating at the current time. Most of Panion BF's value examination focuses on studying past and present price action to predict the probability of Panion BF's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panion BF's price. Additionally, you may evaluate how the addition of Panion BF to your portfolios can decrease your overall portfolio volatility.